For years, Dexcom has been one of the leading competitors in the continuous glucose monitoring space. While the company is focused on looking ahead, that’s not to say there haven’t been some bumps in ...
To follow up on what it’s described as its “best year ever,” Dexcom has accelerated the development of the newest version of its mainstay continuous glucose monitor in 2021—and delivered new clinical ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback